Home LiteratureArticle Details
PMID: 4563493 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article

Parkinson's disease. Modification by 5-hydroxytryptophan.

Neurology ·Vol. 22 ·No. 5 ·1972-05-00 ·Pages 479-84

Chase TN, Ng LK, Watanabe AM

Abstract

暂无摘要

MeSH Terms
5-Hydroxytryptophan/therapeutic use Adult Aged Brain/metabolism Carboxy-Lyases/antagonists & inhibitors Clinical Trials as Topic Drug Synergism Evaluation Studies as Topic Extrapyramidal Tracts/drug effects Female Humans Hydrazines/therapeutic use Hydroxyindoleacetic Acid/cerebrospinal fluid Male Methyldopa/therapeutic use Middle Aged Parkinson Disease/cerebrospinal fluid,drug therapy,metabolism Phenylacetates/cerebrospinal fluid Placebos Serotonin/metabolism
Chemicals
Hydrazines Phenylacetates Placebos Serotonin Hydroxyindoleacetic Acid Methyldopa 5-Hydroxytryptophan Carboxy-Lyases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Chase T N
Ng L K
Watanabe A M
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
0028-3878
Published
1972-05-00
Pages
479-84
Language
English
Region
United States
NLM ID
0401060
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]